P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB

• N. Marschner,
• J. Hanselmann,
• S. McGough,
• S. Braun,
• S. Pfizler-Dempfle,
• R. Sandner,
• J. Mohm,
• M. Jaber,
• D. Hamm,
• N. Hamm,
• M. Jaenicke,
• A. Shewade

Affiliations

N. Marschner

1 Outpatient Centre for Interdisciplinary Oncology and Haematology

J. Hanselmann

2 Biostatistics, iOMEDICO, Freiburg, Germany

S. McGough

3 Roche Global Product Development Data Sciences, Genentech, Inc., South San Francisco, CA, United States of America

S. Braun

4 Biometrics and Epidemiology. Roche Pharma AG, Grenzach-Wyhlen

S. Pfizler-Dempfle

5 Oncology and Haematology Outpatient Centre, Kaiserslautern

R. Sandner

6 MVZ for Haematology and Oncology, Passau

J. Mohm

7 Oncology and Haematology Outpatient Centre, Dresden, Germany

M. Jaber

8 Roche Global Access, F. Hoffmann-La Roche Ltd, Basel, Switzerland

D. Hamm

9 Medical Affairs Excellence, Roche Pharma AG, Grenzach-Wyhlen

N. Hamm

10 Medical Department, iOMEDICO

M. Jaenicke

11 Clinical Epidemiology, iOMEDICO, Freiburg, Germany

A. Shewade

3 Roche Global Product Development Data Sciences, Genentech, Inc., South San Francisco, CA, United States of America